JB
Home Help [Feedback] [For Subscribers] [Archive] [Search] --
JB Accepts, published online ahead of print on 4 April 2008
This Article
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
JB.01194-07v1
190/11/3799    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Garcia, D. L.
Right arrow Articles by Dillard, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Garcia, D. L.
Right arrow Articles by Dillard, J. P.

 Previous Article  |  Next Article 

J. Bacteriol. doi:10.1128/JB.01194-07
Copyright (c) 2008, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

Mutations in ampG or ampD affect peptidoglycan fragment release from Neisseria gonorrhoeae

Daniel L. Garcia and Joseph P. Dillard*

Department of Medical Microbiology and Immunology, University of Wisconsin School of Medicine and Public Health, Madison, WI 53706

* To whom correspondence should be addressed. Email: jpdillard{at}wisc.edu.


   Abstract

Neisseria gonorrhoeae releases peptidoglycan fragments during growth. The majority of the fragments released are peptidoglycan monomers, molecules known to increase pathogenesis through the induction of pro-inflammatory cytokines and responsible for the killing of ciliated epithelial cells. In other gram-negative bacteria such as Escherichia coli, these peptidoglycan fragments are efficiently degraded and recycled. Peptidoglycan fragments enter the cytoplasm from the periplasm via the AmpG permease. The amidase AmpD degrades peptidoglycan monomers by removal of the disaccharide from the peptide. The disaccharide and the peptide are further degraded and then are used for new peptidoglycan synthesis or general metabolism. We examined the possibility that peptidoglycan fragment release by N. gonorrhoeae results from defects in peptidoglycan recycling. Deletion of ampG caused a large increase in peptidoglycan monomer release. Analysis of cytoplasmic material showed peptidoglycan fragments as recycling intermediates in the wild-type strain but absent from the ampG mutant. An ampD deletion reduced release of all peptidoglycan fragments and nearly eliminated release of free disaccharide. The ampD mutant also showed a large build-up of peptidoglycan monomers in the cytoplasm. Introduction of an ampG mutation in the ampD background restored peptidoglycan fragment release, indicating that events in the cytoplasm (metabolic or transcriptional regulation) affect peptidoglycan fragment release. The ampD mutant showed increased metabolism of exogenously added free disaccharide derived from peptidoglycan. These results demonstrate that N. gonorrhoeae has an active peptidoglycan recycling pathway and can regulate peptidoglycan fragment metabolism dependent on the intracellular concentration of peptidoglycan fragments.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
Appl. Environ. Microbiol. Infect. Immun. Eukaryot. Cell
Mol. Cell. Biol. J. Virol. Microbiol. Mol. Biol. Rev.
ALL ASM JOURNALS

Copyright © 2008 by the American Society for Microbiology. All rights reserved.